Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE

No-Receipt date 2021-03083 - 11/08/2021
No-Filing date 20210402141 - 11/08/2021
No-Granting date 3108051 - 25/08/2021
No-EPO application date 16706551.5 - 09/02/2016
No-EPO granting date 3256109 - 14/07/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 8/2021 - 15/09/2021
Expiration date 10/02/2036
Kind of title Validation of European Patent
Legal status VALID
Priorities EP1515455410/02/2015/EP
EP1518898208/10/2015/EP
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/498
A61K 47/18
A61K 9/20
A61K 9/48
A61P 35/00
C07D 403/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1343311 ASTEX THERAPEUTICS LIMITED 436 CAMBRIDGE SCIENCE PARK MILTON ROADCAMBRIDGE CAMBRIDGESHIRE CB4 0QA UNITED KINGDOM (GREAT BRITAIN)

Inventors
CodeFirstnameSurname
3447746 BROGGINI, DIEGO FERNANDO DOMENICO

Representatives
CodeFirstnameSurnameAddressTownZip
3098ANNAGIAKOUMIALKAMENOUS 12-14ATHINA (ATTIKIS)10439

Contact
CodeFirstnameSurnameAddressTownZipCountry
8397ANDRONIKIMISIOUANALIPSEOS 23 KAI MARATHONOS 27VRILISSIA (ATTIKIS)15235 GREECE

Owners History

Title Instruments

Payments history 10 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015